Glenmark, JB Pharma, Ajanta, Zydus, Sanofi lead Indian Pharma Market growth during May'2024

livemint.com:

Also Read- Suven Pharmaceuticals share price rises 5% on CDMO Sapala Organics acquisitionDuring May'2024, among the top-20 pharma companies, Glenmark Pharmaceuticals with growth of 18.9% yar-on-year) and JB Pharma with a growth of 13.1% YoY grew at a significantly faster pace (in the listed space) compared to the IPM, suggested Motilal Oswal Financial Services data.Ajanta Pharma with 12.3% year-on-year growth, Zydus Lifesciences with 11.8% growth and Mankind Pharma with 10.8% growth and Cipla with 10.1% growth were among other outperformers in the listed space.Among MNCs Sanofi India with 12.2% growth also stood out and was among significant outperformers. However among key underperformers during the month stood Pfizer, Indoco Remedies, GSK (Glaxosmithkline Pharma), IPCA Laboratories and Alembic, which posted 1-7% yoy growth , suggested analysts data.Among the top-25 companies, Torrent Pharmaceuticals, Abbott, Lupin, JB Pharma and Zydus have gained maximum share over the past six months in the listed space, said analysts at Kotak Institutional Equities.